🚀 VC round data is live in beta, check it out!
Itoco Valuation Multiples
Discover revenue and EBITDA valuation multiples for Itoco and similar public comparables like Neovacs, DanCann Pharma, bioXXmed, Lipigon Pharmaceuticals and more.
Itoco Overview
About Itoco
Itoco Inc is focused on developing and bringing biotech products to the market via co-development and joint venture arrangements with various companies. The company is currently examining various technologies that seek to control and/or identify bio-contaminants such as viruses and bacteria.
Founded
2007
HQ
Employees
3
Website
Sectors
Financials (FY)
EV
$41K
Itoco Stock Performance
Itoco has current market cap of $41K, and enterprise value of $41K.
Market Cap Evolution
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $41K | $41K | — | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialItoco Valuation Multiples
Itoco Financial Valuation Multiples
As of March 11, 2026, Itoco has market cap of $41K and EV of $41K.
Equity research analysts estimate Itoco's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $41K | XXX | $41K | XXX | XXX | XXX |
| EV (current) | $41K | XXX | $41K | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Itoco Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Itoco Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Neovacs | XXX | XXX | XXX | XXX | XXX | XXX |
| DanCann Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| bioXXmed | XXX | XXX | XXX | XXX | XXX | XXX |
| Lipigon Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| Lidds | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Itoco M&A Activity
Itoco acquired XXX companies to date.
Last acquisition by Itoco was on XXXXXXXX, XXXXX. Itoco acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Itoco
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialItoco Investment Activity
Itoco invested in XXX companies to date.
Itoco made its latest investment on XXXXXXXX, XXXXX. Itoco invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Itoco
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Itoco
| When was Itoco founded? | Itoco was founded in 2007. |
| Where is Itoco headquartered? | Itoco is headquartered in United States. |
| How many employees does Itoco have? | As of today, Itoco has over 3 employees. |
| Who is the CEO of Itoco? | Itoco's CEO is Dmitry Viktorovich Lukin. |
| Is Itoco publicly listed? | Yes, Itoco is a public company listed on OTC Pink Sheets. |
| What is the stock symbol of Itoco? | Itoco trades under ITMC ticker. |
| When did Itoco go public? | Itoco went public in 2009. |
| Who are competitors of Itoco? | Itoco main competitors are Neovacs, DanCann Pharma, bioXXmed, Lipigon Pharmaceuticals. |
| What is the current market cap of Itoco? | Itoco's current market cap is $41K. |
| Is Itoco profitable? | No, Itoco is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.